You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SPRO Sale Disclosure
Rajavelu Esther · SEC Form 4 · Filed Nov 10, 2026
Sale
Calculated transaction value
$42.49K
Rajavelu Esther See Remarks
SPRO
Spero Therapeutics
SPRO
Transaction date
Nov 9, 2026
Public filing date
Nov 10, 2026
Filing lag
Filed 1 day later
SPRO daily price context
Close on/before transaction
$1.07
Nov 9, 2026
First close after public filing
$1.02
Nov 11, 2026
Return after filing · so far
-1.96%
Through Nov 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 40,851 shares @ $1.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-455873
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$42.49K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spero Therapeutics, Inc. SPRO Current | Sale | Nov 9, 2026 | $42.49K |